STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

Historical Holders from Q1 2014 to Q3 2025

Symbol
LAB on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
386M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
286M
Holdings value
$372M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
155
Number of buys
61
Number of sells
-62
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 24.2% +11.8% $107M $14.5M 93.4M +15.6% Eli Casdin 25 Nov 2025

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 286M $372M +$7.18M $1.30 155
2025 Q2 281M $337M -$1.08M $1.20 160
2025 Q1 282M $304M +$2.26M $1.08 146
2024 Q4 278M $487M -$5.66M $1.75 142
2024 Q3 281M $543M +$19M $1.93 141
2024 Q2 271M $480M -$2.58M $1.77 142
2024 Q1 265M $719M +$592M $2.71 144
2023 Q4 48.6M $107M +$2.04M $2.21 85
2023 Q3 47.4M $138M +$3.89M $2.90 72
2023 Q2 46.2M $89.1M +$112K $1.93 65
2023 Q1 46.1M $89.9M -$81.9K $1.95 68
2022 Q4 46.5M $54.4M -$820K $1.17 64
2022 Q3 38.6M $42.5M -$7.84M $1.10 59
2022 Q2 43.8M $70.2M -$17.4M $1.60 78
2022 Q1 49.9M $179M -$25.7M $3.59 103
2021 Q4 56.3M $220M -$14.7M $3.92 116
2021 Q3 58.5M $386M +$6.11M $6.59 116
2021 Q2 57.6M $354M -$3.05M $6.16 111
2021 Q1 59M $267M -$44.8M $4.52 131
2020 Q4 65.3M $392M -$13.7M $6.00 143
2020 Q3 66M $490M +$32M $7.43 131
2020 Q2 62.2M $249M -$3.13M $4.01 109
2020 Q1 64.1M $163M -$2.03M $2.54 101
2019 Q4 64M $223M -$9.72M $3.48 97
2019 Q3 63.9M $296M -$69.6M $4.63 123
2019 Q2 70.2M $864M +$79.9M $12.32 132
2019 Q1 64.3M $854M +$81.4M $13.29 131
2018 Q4 49.4M $426M +$92.5M $8.62 98
2018 Q3 38.9M $291M +$6.43M $7.49 79
2018 Q2 38.1M $227M +$6.13M $5.96 83
2018 Q1 37M $216M +$1.84M $5.84 80
2017 Q4 36.7M $217M +$4.38M $5.89 79
2017 Q3 36.2M $182M +$50.2M $5.04 77
2017 Q2 26.3M $106M -$4.7M $4.04 76
2017 Q1 27.1M $154M +$9.95M $5.69 78
2016 Q4 26.9M $196M -$9.63M $7.28 80
2016 Q3 27.2M $218M -$2.95M $8.01 91
2016 Q2 27.3M $246M -$14M $9.03 93
2016 Q1 28.5M $230M -$6.99M $8.07 95
2015 Q4 28.3M $306M -$18.7M $10.81 101
2015 Q3 31.1M $252M -$43.5M $8.11 101
2015 Q2 31M $750M -$49.3M $24.20 105
2015 Q1 30.6M $1.29B +$17M $42.10 103
2014 Q4 30.4M $1.02B +$65.4M $33.73 100
2014 Q3 28.7M $702M +$40.8M $24.50 98
2014 Q2 26.8M $788M -$670K $29.40 104
2014 Q1 26.2M $1.15B +$79.5M $44.07 106